Compare Stocks

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EXETF Extendicare	$5.29 +0.3%	$5.33	$4.10 ▼ $5.83	N/A	N/A	5,369 shs	361 shs
MLCPF Medipharm Labs	$0.06 -1.6%	$0.05	$2.57 ▼ $2.57	N/A	N/A	181,345 shs	48,707 shs
SQIDF SQI Diagnostics	$0.01	$0.01	$0.01 ▼ $0.13	N/A	N/A	165,179 shs	N/A

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EXETF Extendicare	-0.64%	-1.38%	-5.99%	-0.45%	+9.46%
MLCPF Medipharm Labs	-2.85%	-7.80%	+15.80%	+13.08%	-14.35%
SQIDF SQI Diagnostics	0.00%	0.00%	0.00%	0.00%	-60.79%

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EXETF Extendicare	0.0838 of 5 stars	2.0	0.0	1.7	0.0	0.6	0.0	0.0
MLCPF Medipharm Labs	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SQIDF SQI Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EXETF Extendicare	N/A	N/A	$7.00	32.28% Upside
MLCPF Medipharm Labs	N/A	N/A	N/A	N/A
SQIDF SQI Diagnostics	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EXETF Extendicare	N/A	N/A	N/A	N/A	N/A	N/A
MLCPF Medipharm Labs	N/A	N/A	N/A	N/A	N/A	N/A
SQIDF SQI Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EXETF Extendicare	N/A	-$0.26	N/A	∞	N/A	N/A	N/A	N/A	5/15/2024 (Estimated)
MLCPF Medipharm Labs	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
SQIDF SQI Diagnostics	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	5/28/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EXETF Extendicare	$0.48	9.07%	N/A	N/A	N/A
MLCPF Medipharm Labs	N/A	N/A	N/A	N/A	N/A
SQIDF SQI Diagnostics	N/A	N/A	N/A	N/A	N/A

Latest SQIDF, EXETF, and MLCPF Dividends

Announcement	Company	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/21/2024	EXETF Extendicare	$0.0297	6.35%	3/27/2024	3/28/2024	4/15/2024
2/22/2024	EXETF Extendicare	$0.0296	7.04%	2/28/2024	2/29/2024	3/15/2024
1/19/2024	EXETF Extendicare	$0.0299	6.57%	1/30/2024	1/31/2024	2/15/2024

(Data available from 1/1/2013 forward)

Ownership

Institutional Ownership

Company	Institutional Ownership
EXETF Extendicare	9.44%
MLCPF Medipharm Labs	N/A
SQIDF SQI Diagnostics	N/A

Insider Ownership

Company	Insider Ownership
EXETF Extendicare	N/A
MLCPF Medipharm Labs	N/A
SQIDF SQI Diagnostics	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
EXETF Extendicare	23,000	N/A	N/A	Not Optionable
MLCPF Medipharm Labs	28	N/A	N/A	Not Optionable
SQIDF SQI Diagnostics	42	N/A	N/A	Not Optionable

EXETF, MLCPF, and SQIDF Headlines

Source	Headline
	SQUID: China reveals highly-sensitive submarine detector that's cheap msn.com - January 3 at 1:29 PM
	Squid recipes bbc.co.uk - December 19 at 8:45 AM
	Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc., Debt Forgiveness, Voting Trust Agreement and Related Transactions finance.yahoo.com - November 30 at 5:40 PM
	SQI Diagnostics Inc. (SQD.V) ca.finance.yahoo.com - October 3 at 3:37 PM
	Squid-Con Brings Joy To All hackaday.com - August 28 at 9:29 PM
	Argentina makes changes to its squid fisheries policies en.mercopress.com - August 14 at 4:21 PM
	SQI Diagnostics Further Cuts Head Count as Possible Shutdown Looms 360dx.com - June 6 at 2:42 PM
	SQI Diagnostics Reports Internal Restructuring finance.yahoo.com - June 6 at 2:42 PM
	SQI Diagnostics Reports Second Quarter 2023 Results finance.yahoo.com - May 30 at 6:58 PM
	SQI to Focus on Development of Point of Care Products In Respiratory Health prnewswire.com - March 28 at 8:36 AM
	SQI Diagnostics Announces New Capital Markets Consulting Agreement finance.yahoo.com - March 13 at 8:59 AM
	SQI DIAGNOSTICS ANNOUNCES ADDITIONAL $500,000 ADVANCE UNDER PIVOT CREDIT FACILITY AND OPTION GRANTS finance.yahoo.com - March 10 at 6:20 PM
	Four Diagnostic Products in the Pipeline at SQI finance.yahoo.com - March 3 at 3:18 PM
	SQI Diagnostics Reports First Quarter 2023 Results finance.yahoo.com - March 1 at 7:04 PM
	SQI Diagnostics Reports Fourth Quarter and Fiscal 2022 Results finance.yahoo.com - January 31 at 12:49 AM
	SQI Diagnostics Inc. Closes Second Tranche of Private Placement finance.yahoo.com - December 16 at 7:34 PM
	SQI Diagnostics Inc. announces private placement of $1M canadianmanufacturing.com - November 27 at 10:56 AM
	SQI Diagnostics Inc. Announces Private Placement of $1.0 Million finance.yahoo.com - November 24 at 7:13 PM
	DISPOSITION OF COMMON SHARES OF SQI DIAGNOSTICS INC. finance.yahoo.com - November 24 at 2:00 PM
	SQI Diagnostics Secures Up To $2 Million in FedDev Ontario Funding finance.yahoo.com - November 10 at 11:24 PM
	Health Canada approves SQI Diagnostics’ RALI-Dx Severity Triage Test pharmabiz.com - October 19 at 11:33 AM
	SQI Diagnostics Announces Health Canada Approval of RALI-Dx Severity Triage Test finance.yahoo.com - October 17 at 11:55 AM
	SQI Diagnostics Reports Third Quarter 2022 Results finance.yahoo.com - August 29 at 10:50 AM
	SQI Diagnostics (CVE:SQD) shareholders have endured a 26% loss from investing in the stock a year ago finance.yahoo.com - June 20 at 12:05 PM

Media Sentiment Over Time

Company Descriptions

Extendicare

OTCMKTS:EXETF

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Medipharm Labs

OTCMKTS:MLCPF

MediPharm Labs Corp. primarily focuses on producing pharma-grade cannabis oil and concentrates in Canada. It also focuses on providing cannabis contract processing services to licensed producers and growers; supplying cannabis oil to companies for sale under its brand; and supplying raw materials and processing for the creation of ready-to-sell cannabis products. The company was founded in 2015 and is headquartered in Barrie, Canada.

SQI Diagnostics

OTCMKTS:SQIDF

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial